A trial funded by Nestle has found that infant formula enriched with milk-derived oligosaccharides (MOS), a prebiotic, has helped to improve gut microbiota in babies, such as increasing the abundance of Bifidobacterium.
You May Also Like

Bifidobacterium probiotic may incur “remarkable” benefits to infant gut, study finds
INCMarch 27, 2023

Study: Fucosylated HMOs may improve infant cognitive development, whilst sialyated types may not
INCMarch 27, 2023

Global conference on infant nutrition in Wellington
INCOctober 17, 2022